Ушбу иш иқтибос қилган ишлар

80 та иш

Иш: Novel pyrazolo[3,4-d]pyrimidines as potential anticancer agents: Synthesis, VEGFR-2 inhibition, and mechanisms of action

1. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug

   Renaud Capdeville, Elisabeth Buchdunger, Juerg Zimmermann +1

   Шарҳ мақола20022 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.072984

2. Design, Synthesis, and Evaluation of Isaindigotone Derivatives To Downregulate <i>c-myc</i> Transcription via Disrupting the Interaction of NM23-H2 with G-Quadruplex

   Chan Shan, Jinwu Yan, Yuqing Wang +9

   Мақола20172 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.072987

3. Novel SERMs based on 3-aryl-4-aryloxy-2H-chromen-2-one skeleton - A possible way to dual ERα/VEGFR-2 ligands for treatment of breast cancer

   Guoshun Luo, Xinyu Li, Guoqing Zhang +5

   Мақола20172 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.072990

4. A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis

   Taha Azad, Helena J. Janse van Rensburg, Elizabeth D. Lightbody +13

   Мақола20182 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.072993

5. Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy

   Brandt C. Huddle, Edward Grimley, Cameron D. Buchman +13

   Мақола20182 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.072998

6. Glycosylation in health and disease

   Colin Reily, Tyler J. Stewart, Matthew B. Renfrow +1

   Шарҳ мақола20192 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.073004

7. Density Functional Theory, Chemical Reactivity, Pharmacological Potential and Molecular Docking of Dihydrothiouracil-Indenopyridopyrimidines with Human-DNA Topoisomerase II

   Mohamed E. Elshakre, Mahmoud A. Noamaan, H. Moustafa +1

   Мақола20202 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.073008

8. Synthesis, biological evaluation and molecular docking studies of novel thiopyrimidine analogue as apoptotic agent with potential anticancer activity

   Hesham Haffez, Heba Taha, Maha Abubakr Feissal Rabie +2

   Мақола20202 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.073014

9. Design, synthesis, and cytotoxic activities of isaindigotone derivatives as potential anti-gastric cancer agents

   Kangjia Du, Wantong Ma, Cheng‐Jie Yang +10

   Мақола20222 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.073027

10. A Novel Isaindigotone Derivative Displays Better Anti-Proliferation Activities and Induces Apoptosis in Gastric Cancer Cells

    Kangjia Du, Cheng‐Jie Yang, Zhongkun Zhou +9

    Мақола20222 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.073030

11. Сарлавҳасиз

    Бошқа2 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.073033

12. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.072960

13. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.072961

14. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.072964

15. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.072966

16. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.072967

17. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.072969

18. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.072970

19. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.072971

20. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.072973

21. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.072974

22. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.072975

23. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.072977

24. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.072979

25. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.072981